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Objectives. This study was undertaken to determine which 
exercise and radionuclide ventriculographic variables predict 
prognosis in advanced heart failure. 
Background. Although cardiopulmonary exercise testing is 
frequently used to predict prognosis in patients with advanced 
heart failure, little is known about the prognostic significance of 
ventriculographic variables. 
Methods. The results of maximal symptom-limited cardiopul- 
monary exercise testing and first-pass radionuclide ventriculog- 
raphy in patients with advanced heart failure referred for evalu- 
tion for cardiac transplantation were analyzed. 
Results. Sixty-seven patients with advanced heart failure (mean 
[_+ SD]; age 51 -+ 10 years, New York Heart Association functional 
classes III (58%) and IV (18%); mean left ventricular ejection 
fraction 0.22 -+ 0.07) underwent simultaneous upright bicycle 
ergometric cardiopulmonary exercise testing and first-pass rest/ 
exercise radionuclide ventriculography. Mean peak oxygen con- 
sumption 0(02) was 11.8 -+ 4.2 ml/kg per min, and mean peak age- 
and gender-adjusted percent predicted oxygen consumption 
(%Vo 2) was 38 +- 11.9%. Univariate predictors of overall survival 
included right ventricular ejection fraction >0.35 at rest and 
>0.35 at exercise and %Vo 2 _>45% (all p < 0.05). In a multivariate 
proportional hazards survival model, right ventricular ejectioa 
fraction >0.35 at exercise (p < 0.01) and %Vo 2 >45% (p = 0.01) 
were selected as independent predictors of overall survival. Uni- 
variate predictors of event-free survival included right ventricular 
ejection fraction >0.35 at rest (p = 0.01) and >0.35 at exercise 
(p < 0.01), functional class II (p < 0.05) and %Vo 2 ->45% (p = 
0.05). Right ventricular ejection fraction >0.35 at exercise (p ---- 
0.01) was the only independent predictor of event-free survival ia 
a multivariate proportional hazards model. Cardiac index at resl:, 
Voz, left ventricular ejection fraction at rest, and exercise-relatot 
increase or decrease >0.05 in left or right ventricnlar ejection 
fraction were not predictive of overall or event-free survival in any 
univariate or multivariate analysis. 
Conclusions. 1)Right ventricular ejection fraction >0.35 at rest 
and exercise is a more potent predictor of survival in advanced 
heart failure than Vo 2 or %Vo2; 2) %Voz rather than Vo 2 predicts 
survival in advanced heart failure; 3) neither %Vo 2 nor Vo 2 
predicts urvival to the combined end point of death or admissioa 
for inotropic or mechanical support in patients with advanced 
heart failure. 
(J Am CoU Cardiol 1995;25:1143-53) 
Despite recent advances in medical and surgical therapy, 
patients with symptomatic congestive heart failure still have a 
generally poor prognosis (1). A variety of clinical, hemody- 
namic and ventriculographic variables, including age, presence 
of a third heart sound ($3) ventricular gallop, left ventricular 
ejection fraction, left ventricular end-diastolic volume index, 
pulmonary capillary wedge pressure and pulmonary vascular 
resistance, have been shown to predict prognosis in large 
groups of patients with heart failure with symptoms of varying 
severity (2-16). Markers of reflex neurohumoral activation, 
such as plasma norepinephrine, plasma renin activity and atrial 
naturietic peptide, are elevated in heart failure and have also 
been shown to portend a poorer prognosis in similar groups 
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(17-20). However, considerable difficulty remains in estimating 
the prognosis of a subgroup of patients at greatest risk--those 
with advanced heart failure referred for evaluation for cardiac 
transplantation (21). In this more homogeneous patient group, 
conventional clinical, hemodynamic and neurohumoral pre- 
dictors of prognosis have not been shown to be as useful in pre- 
dicting outcome. 
Functional capacity assessed by peak oxygen consumption 
(peak Vo2) during cardiopulmonary exercise testing has been 
shown to predict survival in advanced heart failure (21-231,. 
Peak Vo 2 <10 ml/kg per min is associated with the poorest 
prognosis, and such patients are often recommended for 
cardiac transplantation (21). Peak Vo 2 >14 ml/kg per rain 
predicts overall 2-year survival at least equivalent to that for 
cardiac transplantation, and such patients are usually followed 
on medical therapy. Patients with peak Vo 2 between 10 and 14 
ml/kg per min have an intermediate prognosis. 
Despite the utility of peak Vo: in risk stratification ~f 
patients with advanced heart failure, little is known about 
additional prognostic features that can be identified during 
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cardiopulmonary exercise testing. This study attempted to 
determine whether est and peak exercise first-pass radionu- 
clide ventriculography performed uring simultaneous cardio- 
pulmonary exercise testing might provide any additional prog- 
nostic information beyond that obtained by measurement of 
peak Vo2. 
Methods  
Study patients. The study group included 67 ambulatory 
patients with advanced, symptomatic heart failure referred for 
evaluation for cardiac transplantation between 1988 and 1992 
to the Massachusetts General Hospital Heart Failure Center. 
All patients underwent simultaneous cardiopulmonary exer- 
cise testing and rest and peak exercise first-pass radionuclide 
ventriculography aspart of initial evaluation for cardiac trans- 
plantation. Patients unable to exercise because of a require- 
ment for intravenous inotropic agents or mechanical circula- 
tory support were excluded. Mean (_+SD) patient age was 51 _+ 
10 years (range 17 to 61), and 79% were male. Heart failure 
etiology was ischemic (46%) or dilated (54%) cardiomyopathy; 
24% of patients were in New York Heart Association func- 
tional class II, 58% in class III, and 18% in class IV. Before 
cardiopulmonary exercise testing, medical therapy with 
digoxin, diuretic drugs and angiotensin-converting enzyme 
inhibitors had been optimized on the basis of symptoms, 
physical examination, renal function and, in most instances, 
invasive hemodynamic monitoring. Therapy was adjusted to 
achieve apulmonary capillary wedge pressure <18 mm Hg and 
cardiac index >2.2 liters/rain per m a whenever possible. 
Exercise testing and radionuclide ventriculography. Exer- 
cise testing was performed after an overnight fast; oral medi- 
cations were not withheld. Upright symptom-limited cycle 
ergometry was performed on an electronically braked bicycle 
ergometer (pedal-mode ergometer, Warren E. Collins, Inc.) at 
a constant cycle speed of 60 rpm using a continuous ramp 
protocol in which work load increased continuously by 
12.5 W/min up to peak tolerance. Heart rate, blood pressure 
and the 12-lead electrocardiogram were monitored con- 
tinuously. Predicted maximal heart rate was estimated as 
220 beats/rain minus age. Peak work load (W) and exercise 
duration (rain) were noted. Breath-to-breath respiratory gas 
exhange analysis was performed by means of a mouthpiece and 
nose clips and a metabolic cart (2001 System, Medical Graph- 
ics Corp.). 
Rest ventilatory and gas exchange data were averaged over 
the last 2 rain of the rest period. During exercise, data were 
averaged over contiguous 30-s intervals, except at peak exer- 
cise, when 15-s averaging was used to improve time resolution. 
Oxygen uptake, carbon dioxide output, respiratory quotient, 
minute ventilation and ventilatory equivalent for oxygen were 
calculated by on-line computer as previously reported (24). 
The anaerobic threshold was determined by the V slope 
method (25). Maximal oxygen uptake (peak Vo2) was defined 
as the highest Vo 2 measured uring the last minute of 
symptom-limited xercise. Predicted values for maximal oxy- 
gen consumption during upright bicycle exercise were calcu- 
lated from a gender-specific regression equation incorporating 
age, height and weight (26). 
Rest and peak exercise first-pass radionuclide ventriculog- 
raphy were performed with a multicrystal gamma camera 
(Baird-Atomic System 77, Baird Corporation) in the anterior 
view with the patient upright at rest and at peak exercise. Red 
blood cells were pretreated with 3 ml of intravenous stannous 
pyrophosphate 20 min before first-pass radionuclide ventricu- 
lographic imaging. Images were acquired at 0.025 s/frame after 
the intravenous bolus administration f 10 mCi of technetium- 
99m (Tc-99m) pertechnetate at rest and after a second intra- 
venous bolus of 15 mCi Tc-99m pertechnetate t peak exercise. 
Each study was completed within 50 s. 
Data were stored and analyzed with the use of MAC77 
software (Scinicor Inc.). A region of interest was selected over 
each ventricle, and a time-activity curve was generated. Peak 
activity was considered to be end-diastole, and the activity 
minimum was considered to be end-systole. Only cycles with 
>70% of the maximal end-diastolic activity in the end-diastolic 
frame were included for analysis. Background was taken as the 
activity within the ventricular region of interest before the first 
ventricular beat. The background-subtracted ventricular beats 
were summated to generate a single representative cardiac 
cycle. The right and left ventricular ejection fractions were 
derived from time-activity curves as (End-diastolic ounts -
End-systolic counts)fEnd-diastolic counts. Previous studies 
from our laboratory (27) have demonstrated anejection frac- 
tion estimation i terobserver ror of _+4% for this method of 
ejection fraction calculation. The left ventricular end-diastolic 
and end-systolic volumes were calculated from the regions of 
interest with the use of a single-plane area-length method and 
divided by the body surface area to obtain the left ventricular 
end-diastolic and end-systolic volume indexes. Left ventricular 
stroke volume index was calculated as end-diastolic volume 
index minus end-systolic volume index. 
Preserved right ventricular ejection fraction at rest was 
defined as right ventricular ejection fraction ->0.35, the lower 
limit for right ventricular ejection fraction within 2 SD of the 
mean right ventricular ejection fraction measured in our 
laboratory in 16 healthy sedentary volunteer control subjects. 
In accord with previous published studies (28-31), an increase 
in rest left or right ventricular ejection fraction ->0.05 at peak 
exercise was considered normal. 
Clinical follow-up and outcome. Medical therapy was op- 
timized before hospital discharge. After initial evaluation for 
transplantation, patients were followed up every 3 to 6 months 
at the Massachusetts General Hospital Heart Failure Center. 
Outpatient medical therapy was adjusted as necessary to 
achieve an edema-free state and maximally tolerated ose of 
vasodilator therapy. 
Follow-up data were collected by review of all Massachu- 
setts General Hospital and clinic records and telephone inter- 
view of the referring physician, patient or patient's family. 
Follow-up data collected included date of death, date of 
transplantation, need for admission to hospital for inotropic or 
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mechanical support before transplantation a d number and 
timing of hospital admissions for decompensated heart failure. 
Follow-up information up to the time of analysis was available 
for all 67 patients. 
Deaths occurring within 24 h without antecedent symptom- 
atic progression of heart failure were defined as sudden. 
Deaths from progressive symptoms of hemodynamic deterio- 
ration were defined as due to progressive heart failure. Two 
study end points were defined: 1) death (either sudden or from 
progressive heart failure) and 2) a combined end point of 
either death or pretransplantation admission for inotropic or 
mechanical bridging to cardiac transplantation. 
Statistical analysis. Univariate and multivariate analyses 
were performed to determine which demographic, exercise- 
derived and radionuclide ventriculographic variables were 
predictive of the two study end points, 1) death, and 2) the 
combined end point. Univariate and multivariate analyses for 
each end point were performed separately. Univariate and 
multivariate analyses of survival to each end point were also 
performed separately. Overall survival was defined as freedom 
from death (sudden or due to progressive heart failure); 
event-free survival was defined as freedom from the combined 
end point (death or intotropic/mechanical bridging to trans- 
plantation). 
To allow clinically meaningful nivariate and multivariate 
comparisons between groups, the following continuous vari- 
ables were analyzed as stratified ordinal variables: peak Voz 
(-<10, >10 to <14 and ->14 ml/kg per min); peak percent 
predicted age- and sex-adjusted Vo 2 (-<30, >30 to <45 and 
->45 ml/kg per min); right ventricular ejection fraction at rest 
or exercise (<0.35 or ->0.35); left ventricular ejection fraction 
at rest (-<0.20, >0.20 to <0.30, and ->0.30); left ventricular 
end-diastolic volume index at rest (<150 or ->150 ml/m2); 
left ventricular end-systolic volume index at rest (<120 or 
->120 ml/m2); and cardiac index at rest (<2.8 or ->2.8 liters/ 
m2). A right ventricular ejection fraction at rest or exercise 
>-0.35 was considered preserved right ventricular ejection 
fraction in accord with studies at our and other institutions 
(27). Right and left ventricular ejection fraction discordance 
("ventricular discordance") was defined as right ventricular 
ejection fraction at rest minus left ventricular ejection fraction 
at rest ->0.10. Peak Vo2 and peak %Vo 2 were stratified into 
three groups in accord with previous tudies (22) and to allow 
maximal opportunity o detect significant univariate and mul- 
tivariate associations with other variables. Left ventricular 
end-diastolic volume index, left ventricular end-systolic volume 
index and cardiac index were stratified by the mean values for 
the study group. All analyses were performed using these 
stratified variables, which were recorded for all 67 patients. 
Because of radionuclide first-pass bolus dispersion, seven 
patients did not have accurate determination f left ventricular 
ejection fraction at peak exercise or left ventricular end- 
diastolic volume index at peak exercise; these variables were 
therefore not included in any univariate or multivariate anaL- 
yses. 
Univariate differences between groups were compared by 
Fisher exact ests for dichotomous variables, Mantel-Haenszel 
chi-square tests for trend for nondichotomous ordinal vari- 
ables, nonpaired t tests for normally distributed continuous 
variables and Wilcoxon rank-sum tests for nonnormally distrib- 
uted continuous variables. Multivariate logistic regression was 
used to identify the most important predictors of death and the 
combined end point. Multiple linear best possible all-subsets 
regression was used to identify the predictors of peak %Vo 2. 
Life-table analysis was used to determine overall and 
event-free survival for the entire study group, Differences in 
overall and event-free survival between groups were detected 
by the Kaplan-Meier product-limit method and compared 
by the Peto-Prentice generalized log-rank test for two groups 
or the Peto-Prentice generalized log-rank test for trend for more 
than two groups. To identify the most important predictors of 
overall and event-free survival, multivariate Cox proportional 
hazards analysis was used. In analyses of overall survival, cardiac 
transplantation was considered a censored observation; i  analy- 
ses of event-free survival, hospital admission for inotropic or 
mechanical bridging to transplantation was considered a noncen- 
sored observation, and elective admission for transplantation 
without inotropic/mechanical bridging was considered a censored 
observation. 
A p value <0.05 was considered statistically significant. All 
analyses were performed by BMDP statistical software. 
Resu l ts  
Clinical characteristics, cardiopuimonary exercise testing 
results and radionuclide ventriculographic findings. The clin- 
ical characteristics and results of cardiopulmonary exercise 
testing and first-pass radionuclide ventriculography are pre- 
sented in Table 1. Medical therapy included digoxin (79%), 
diuretic drugs (83%), angiotensin-converting enzyme inhibi- 
tots (77%), hydralazine (8%) and vesnarinone (5%); 29% of 
patients were receiving type 1A or type 3 antiarrhythmic 
agents. An automatic implantable cardioverter-defibrillator 
had previously been implanted in 17% of patients. 
There were no significant adverse outcomes during cardio- 
pulmonary exercise testing; three patients experienced tran- 
sient angina. At peak exercise, mean systolic blood pressure 
was 120 _+ 24 mm Hg, mean peak heart rate was 134 _+ 
37 beats/min, and mean age-adjusted peak heart rate achieved 
82 +_ 22% (Table 1). Mean peak Vo 2 was 11.8 _+ 4.2 ml/kg per 
min (range 6.2 to 28.7). Division into strata revealed that 24 
patients (36%) had a peak Vo 2 <10 ml/kg per min, 26 (39%) 
had a peak Vo 2 between 10 and 14 ml/kg per rain, and 17 
(25%) had a peak Vo2 >14 ml/kg per min. Mean peak %Vo2 
was 38 _+ 12%. Further division into strata revealed that 15 
patients (22%) had peak %Vo 2 <30%, 32 (48%) had peak 
%Vo 2 between 30% and 45%, and 20 (30%) had peak %Vo2 
>45%. Mean respiratory gas-exchange ratio at peak exercise 
was 1.13 _+ 0.19; mean anaerobic threshold was 7.9 +_ 2.3 ml/kg 
per min; and mean anaerobic threshold as a percent of peak 
Vo z was 66.7 _+ 11%. 
Mean left ventricular ejection fraction at rest was 0.22 _+ 
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Table 1. Clinical Characteristics and Exercise and Radionucl ide 
Findings in 67 Patients 
Age (yr) 51 +_ 10 (17-61) 
Gender (%) 
Male 79 
Female 21 
NYHA (%) 
II 24 
III 58 
IV 18 
Etiology (%) 
Ischemic CM 46 
Nonischemic CM 54 
SBP, rest (ram Hg) 104 _+ 17 (80-170) 
SBP, ex (ram Hg) 120 _+ 24 (75 174) 
HR, rest 87 _+ 20 (54-143) 
HR, ex 134 _+ 37 (60-300) 
MPHR (%) 82 _+ 22 (39-176) 
Watts 73 _+ 34 (23-188) 
Vo z (ml/kg per min) 11.8 ~ 4.2 (6.2-28.7) 
%Vo2 38 _+ 12 (17-62) 
R (ex) 1.13 _+ 0.19 (0.68-1.65) 
AT (ml/kg per min) 7.9 _+ 2.3 (2.9-14.2) 
AT% peak Vo 2 66 _+ ll (44-99) 
LVEF, rest 0.22 + 0.07 (0.9-0.39) 
LVEF, ex 0.24 = 0.07 (0.9-0.40) 
RVEF, rest 0,29 + 0.ll (0.10-0.53) 
RVEF, ex 0.28 _+ 0.ll (0.13-0.56) 
LVEDVI, rest (ml/m z) 155 -+ 48 (90-388) 
LVESVI, rest (ml/m 2) 121 _+ 47 (41-352) 
CI, rest (liters/rain per m z) 2.9 _+ 0.8 (1.8-4.8) 
Data presented are mean value _+ SD (range) or percent of patients. AT = 
anaerobic threshold; AT %Vo 2 = anaerobic threshold as a percent of measured 
peak Vo2; CI = cardiac index; CM = cardiomyopathy; ex - exercise; HR - 
heart rate; LVEDVI = left ventricular end-diastolic volume index; LVEF - left 
ventricular ejection fraction; LVESVI - left ventricular end-systolic volume 
index; MPHR = maximal predicted heart rate; NYHA = New York Heart 
Association functional class; R = respiratory exchange ratio; RVEF = right 
ventricular ejection fraction; SBP = systolic blood pressure; Voz = peak oxygen 
consumption; %Vo 2 - peak percent predicted oxygen consumption. 
0.07 (range 0.09 to 0.39) and did not increase significantly 
during exercise (left ventricular ejection fraction at peak 
exercise 0.24 _+ 0.07, p = NS). At peak exercise left ventricular 
ejection fraction increased ->0.05 in 11 patients (17%) and 
decreased ->0.05 in 4 (6%). Mean right ventricular ejection 
fraction at rest was also depressed at 0.29 _+ 0.11 (range 0.10 to 
0.53) and did not increase significantly with exercise (right 
ventricular ejection fraction at peak exercise 0.28 _+ 0.11, p = 
NS). At peak exercise, right ventricular ejection fraction 
increased >0.05 in 12 patients (18%) and decreased ->0.05 in 
11 (17%). A total of 24 patients (36%) had a right ventricular 
ejection fraction at rest ->0.35 (preserved right ventricu- 
lar ejection fraction)• There was no difference in left ventric- 
ular ejection fraction at rest between patients with preserved 
or nonpreserved right ventricular ejection fraction at rest (left 
ventricular ejection fraction 0.22 + 0.07 vs. 0.23 _+ 0.07, 
respectively, p = 0.60). Overall, 29 patients (43%) exhibited 
ventricular discordance at rest. There was no difference in 
0.8 
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Figure 1. Life-table analysis of survival for the entire study group: 
solid l ine = overall survival; dotted line = event-f lee survival. 
duration of heart failure symptoms or diagnosis (ischemic vs. 
dilated cardiomyopathy) between those patients with and 
without ventricular discordance. Mean left ventricular end- 
systolic volume index was 121 _+ 47 ml/m 2 at rest. 
Outcome and survival. Sixty patients (90%) were deemed 
suitable candidates and were eventually listed for cardiac 
transplantation. Median duration of follow-up was 58 weeks 
(range 1 to 180). Seventeen patients (23%) were admitted to 
the hospital for exacerbation fheart failure (excluding admis- 
sions for inotropic/mechanical support as bridging to trans- 
plantation); 30 patients (45%) required an increased ose of 
an established or a new diuretic drug; and 13 patients (20%) 
required an increased ose of angiotensin-converting e zyme 
inhibitor during follow-up. Only 1 of the 17 patients with an 
automatic implantable cardioverter-defibrillator experienced 
an automatic implantable cardioverter-defibrillator firing dur- 
ing follow-up. 
Sixteen patients (24%) died, of whom 14 (88%) died out of 
hospital and suddenly. Two nonsudden deaths occurred in 
hospitalized patients awaiting transplantation (progressive 
heart failure [n = 1]; intractable heart failure during an episode of 
catheter-related sepsis [n = 1]). 
A total of 29 patients (42%) reached the combined end 
point of death (n = 16) or hospital admission for inotropic/ 
mechanical bridging to transplantation (  = 13). Among the 23 
patients (35% of the study group) who underwent transplan- 
tation, 13 (56% of all who underwent transplantation) were 
admitted for inotropic/mechanical bridging before transplan- 
tation; 10 patients (44% of all who underwent transplantation) 
underwent transplantation asoutpatients. 
By life-table analysis, median overall survival was estimated 
to be 140 weeks and median event-free survival 98 weeks 
(Fig. 1). 
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Table 2. Univariate and Multivariate Predictors ofDeath and 
Combined End Point 
Death Combined End Point 
Predictor (p value) (p value) 
Univariate 
Age 0.06 0.16 
Gender 0.18 0.78 
Diagnosis 1.0 0.81 
NYHA 0.05 0.05 
MPHR 0.71 0.37 
Peak Vo 2 0.34 0.47 
Peak %Vo2 0.04* 0.31 
RVEF <0.35, rest 0.04* 0.01" 
RVEF <0.35, ex 0.05 0.01" 
LVEF, rest 0.10 0.29 
Discordance 0.04" 0.22 
LVEDVI, rest 0.38 0.06 
LVESVI, rest 0.93 0.22 
CI, rest 0.39 0.63 
AICD 0.27 0.22 
Multivariate 
RVEF, rest 0.04* - -  
RVEF, ex - -  0.03* 
*p < 0.05. AICD = automatic mplantable cardioverter-defibrillator; ther 
abbreviations as in Table 1. 
Table 3. Univariate and Multivariate Predictors ofOverall and 
Event-Free Survival 
Overall Survival Event-Free Survival 
Predictor (p value) (p value) 
Univariate 
Age 0.30 0.16 
Gender 0.38 0.22 
Diagnosis 0.84 0.83 
NYHA 0.06 0.03" 
MPHR 0.36 0.36 
Peak Vo z 0.44 0.93 
Peak %V% 0.02* 0.05 
RVEF ->0.35, rest 0.03* 0.02* 
RVEF ->0.35, ex 0.02* 0.01' 
LVEF rest 0.24 0.30 
Discordance 0.06 0.10 
LVEDVI, rest 0.83 0.08 
LVESVI, rest 0.65 0.17 
CI, rest 0.34 0.62 
AICD 0.11 0.20 
Multivariate 
RVEF ->0.35, ex 0.006* 0.016' 
Peak %Vo 2 0.010' NS 
Age 0.013" NS 
*p < 0.05. Abbreviations as in Tables 1 and 2. 
Predictors of death and combined end point. From among 
the clinical, exercise and radionuclide variables recorded 
during cardiopulmonary exercise testing (age, gender, diagno- 
sis, functional class, percent predicted heart rate maximum 
achieved, peak Vo 2, peak %Vo2, watts achieved, right ventric- 
ular ejection fraction at rest and at exercise, left ventricular 
ejection fraction at exercise, right and left ventricular ejection 
fraction discordance, left ventricular end-diastolic volume in- 
dex and left ventricular end-systolic volume index at rest and 
cardiac index at rest), four significant univariate predictors of 
death were identified: right ventricular ejection fraction <0.35 
at rest and <0.35 at exercise, peak %Vo 2 <30% and ventric- 
ular ejection fraction discordance (Table 2). Peak Vo 2 was not 
a significant predictor of death in this patient group when 
analyzed as a continuous, binary (<14 or ->14 ml/kg per min) 
or stratified ordinal (-<10, >10 to <14, ->14 ml/kg per min) 
variable. In multivariate logistic regression analysis, right ven- 
tricular ejection fraction <0.35 at rest was selected as the most 
potent predictor of death. 
From among the same candidate clinical, exercise-derived 
and radionuclide ventriculographic variables, three significant 
predictors of the combined end point were identified: right 
ventricular ejection fraction <0.35 at rest and <0.35 at exer- 
cise and functional class IV (Table 2). Left ventricular end- 
diastolic volume index >175 ml/m 2 was a nearly significant 
univariate predictor of the combined end point. Neither peak 
Vo 2 nor peak %Vo 2 analyzed as either continuous, discrete 
binary or discrete stratified variables were significant predic- 
tors of the combined end point. In multivariate logistic regres- 
sion analysis, right ventricular ejection fraction <0.35 at exer- 
cise was the most potent predictor of the combined end point. 
An increase or decrease in either right or left ejection 
fraction at peak exercise was not predictive of death or the 
combined end point in any univariate or multivariate analysis. 
Survival analysis. Univariate and multivariate predictors 
of overall survival are presented in Table 3. Significant univa- 
riate predictors of overall survival included age, peak %Vo2 
->45%, right ventricular ejection fraction ->0.35 at rest and 
->0.35 at exercise and functional class II. Peak Vo2 was not 
predictive of overall survival as either a discrete binary or 
stratified variable. Overall survival stratified by peak Vo 2, peak 
%Vo 2 and right ventricular ejection fraction at rest is displayed 
in Figure 2. In a Cox proportional hazards model of overall 
survival, age, peak %Vo2 and right ventricular ejection fraction 
->0.35 at exercise were selected as independent predictors of 
overall survival (Table 3). 
Univariate and multivariate predictors of event-free sur- 
vival are presented inTable 3. Significant univariate predictors 
of event-free survival included functional class II, right ven- 
tricular ejection fraction ->0.35 at rest and ->0.35 at exercise 
and peak %Vo 2 ->45%. Event-free survival stratified by peak 
Vo2, peak %Vo2, and right ventricular ejection fraction at rest 
is displayed in Figure 3. In a Cox proportional hazards model, 
only right ventricular ejection fraction ->0.35 at exercise was 
found independently o predict event-free survival (Table 3). 
An increase or decrease in right or left ejection fraction at 
peak exercise was not predictive of overall or event-free 
survival in any univariate or multivariate analysis. 
Predictors of peak age- and gender-adjusted peak %Vo2 
achieved. The relation among right and left ejection fraction 
at rest, peak V% and peak %go 2 is displayed in Figure 4. Sig- 
nificant univariate predictors of peak %Vo 2 included percent 
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Figure 2. Log-rank analysis of overall survival stratified by peak 
oxygen uptake (Vo2), peak age- and gender-adjusted %Vo 2 and rest 
right ventricular ejection fraction. Top, Overall survival stratified by 
peak Vo2: solid line = Vo2 -<10 ml/kg per rain; dotted line = Vo 2 10 
to 14 ml/kg per min; dashed line = Vo 2 ->14 ml/kg per min. Middle, 
Overall survival stratified by peak %Vo2: solid line = %Vo 2 <30%; 
dotted l ine = %Vo 2 30% to 45%; dashed l ine = %Vo 2 ->45%. 
Bottom, Overall survival stratified by right ventricular ejection fraction 
at rest: solid line = right ventricular ejection fraction <0.35; dotted 
line = right ventricular ejection fraction ->0.35. 
Cumulat ive  surv iva l  
1 . 
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Figure 3. Log-rank analysis of event-free survival stratified by peak 
oxygen uptake (Vo2), peak age- and gender-adjusted %Vo2 and rest 
right ventricular ejection fraction. Top, Event-free survival stratified by 
peak Voz: solid line = Vo z <10 ml/kg per rain; dotted line - Vo 2 10 
to 14 ml/kg per min; dashed line = Vo 2 ->14 ml/kg per min. Middle, 
Event-free survival stratified by peak %Vo2: solid line = %Vo 2 
-<30%; dotted l ine = Vo 2 30% to 45%; dashed l ine = %Vo 2 ->45%. 
Bottom, Event-free survival stratified by right ventricular ejection 
fraction at rest: solid line - right ventricular ejection fraction <0.35; 
dotted l ine - right ventricular ejection fraction ->0.35. 
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maximal heart rate achieved, right ventricular ejection fraction 
->0.35 at rest and ->0.35 at exercise, ventricular ejection fraction 
discordance, l ft ventricular end-systolic volume index, functional 
class II and systolic blood pressure at peak exercise (Table 4). Left 
ventricular ejection fraction at rest, an increase or decrease in 
either left or fight ejection fraction at peak exercise, left ventric- 
ular end-diastolic volume index, systolic blood pressure at rest 
and cardiac index at rest were not predictive of peak %Vo2. A 
multivariate linear regression analysis from all significant univa- 
riate candidate variables identified right ventricular ejection frac- 
tion ->0.35 at rest and percent maximal heart rate achieved as 
independent predictors of peak %Vo 2. 
Comparison of patients by right ventricular ejection frac- 
tion. There was no difference in age, gender, diagnosis, func- 
tional class, peak V02, percent predicted heart rate achieved, 
left ventricular ejection fraction, left ventricular end-diastolic 
volume index, left ventricular end-systolic volume index, car- 
diac index at rest or duration of symptoms in those patients 
with or without preserved right ventricular ejection fraction 
(Table 5). Patients with preserved right ventricular ejection 
fraction achieved a significantly higher peak %Vo 2 but not 
peak Vo 2 and had longer median overall and event-free 
survival. 
Figure 4. Plots of rest right (RVEF) and left ventricular ejection 
fraction (LVEF) versus peak oxygen uptake (Vo2) and peak %Vo2. 
Top left, Right ventricular ejection fraction versus peak Vo2: r = 0.27, 
p = 0.02. Top right, Right ventricular ejection fraction versus peak 
%Vo2: r = 0,37, p = 0.00l. Bottom left, Left ventricular ejection 
fraction versus peak Vo2: r = 0.05, p = 0.7. Bottom right, Left 
ventricular ejection fraction versus peak %Vo2: r = 0.17, p = 0.15. 
Discuss ion  
The major finding of this study is the importance of right 
ventricular function in the prediction of both overall and 
event-free survival in patients with advanced heart failure. 
Preserved rest or exercise right ventricular ejection fraction 
was found to better predict both overall and event-free survival 
than peak Vo2. Although peak %Vo2 did predict overall and 
event-free survival, it was a less potent predictor than right 
ventricular ejection fraction. In addition, ventricular ejection 
fraction discordance was identified as an important predictor 
of functional capacity in patients with advanced heart failure. 
Right ventricular ejection fraction. Many studies have 
shown that left ventricular ejection fraction, diastolic or sys- 
tolic dimensions and filling pressures predict survival but not 
functional capacity in patients with advanced heart failure (32). 
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Table 4. Univariate and Multivariate Predictors of Peak Age- and 
Gender-Adjusted Peak Oxygen Consumption During 
Cardiopulmonau Exercise Testing 
Predictor p Value 
Univariate 
NYHA 11.05" 
SBP, rest 0.08 
SBP, ex 0.02* 
MPHR 0.004* 
RVEF ->0.35, rest 0.001' 
RVEF >0.35, e× 0.001 *
LVEF, rest 0.15 
Change in RVEF 0.94 
Change in LVEF 0.86 
Discordance 0.003* 
LVEDVI, rest 0.08 
LVESVI, rest 0.04:' 
CI, rest 0.74 
Multivariate 
RVEF >0.35, rest 0.001 * 
MPHR 0.009* 
*p < 0.05. Abbreviations as in Table 1. 
Only a few relatively small studies have reported the prognos- 
tic significance of right ventricular ejection fraction in patients 
with advanced heart failure. Polak et al. (33) reported a 
significantly higher 2-year mortality in patients with a right 
ventricular ejection fraction <0.35 at rest (71% vs. 23%). 
Baker et al. (34) reported that radionuclide right ventricular 
ejection fraction at rest correlated with peak Vo2 (r = 0.7, p < 
0.001) and was superior to left ventricular ejection fraction in 
predicting exercise capacity. By contrast, Szlachcic et al. (35) 
found a significant univariate but not multivariate correlation 
between right ventricular ejection fraction and exercise capac- 
ity. To our knowledge, the present study is the largest reported 
to date to show that in a homogeneous group of patients with 
advanced heart failure, right ventricular ejection fraction at 
rest or exercise predicts both survival and functional capacity 
as assessed by peak V% during exercise. In addition, the 
prognostic importance of right ventricular ejection fraction was 
not dependent on duration or etiology of heart failure. 
That the right ventricle plays an important role in deter- 
mining exercise capacity in advanced heart failure is supported 
by previous clinical trials. Primary venodilators uch as ni- 
trates, which improve right ventricular loading conditions (in 
the case of nitrates by decreasing both right ventricular preload 
and afterload), increase exercise capacity in advanced heart 
failure more than primary arterial vasodilators such as enala- 
pril, which affect right ventricular loading conditions consider- 
ably less (36,37). Patients treated with long-term captopril who 
experience a greater decrease in pulmonary vascular resistance 
(and reduction in right ventricular afterload) have a greater 
improvement in cardiac index, stroke volume index and left 
ventricular stroke work index than those who do not, suggest- 
ing that increased right ventricular output as a result of 
decreased right ventricular afterload leads to increased left 
ventricular filling and output in advanced heart failure (38). 
Table 5. Clinical Characteristics of Patients With Nonpreserved 
Versus Preserved Right Ventricular Ejection Fraction 
Nonpreserved Preserved p Value 
Age (yr) 51 + 9 51 + 11 NS 
Gender (%) 80 76 NS 
Ischemic CM (%) 54 56 NS 
NYHA 3 + 0.06 3 _+ 0.04 NS 
Duration (too) 29 _+ 34 25 + 28 NS 
Peak Vo z l l.3 = 4 12.8 + 4 0.13 
Peak %Vo2 36 _+ 11 43 ± 13 0.009* 
R (ex) 1.15 _+ 0.21 1.12 + 0.15 NS 
AT 7.7 + 2.5 8.2 ± 2.1 NS 
AT %peak Vo 2 67.5 _+ 11.5 65.2 - 10 NS 
MPHR 81 + 22 80 -+ 24 NS 
LVEF, rest 11.22 _+ 0.07 0.23 + 0.07 NS 
LVEDVI, rest 160 2 52 145 + 42 NS 
LVESVI, rest 126 + 50 111 ± 43 0.20 
CI, rest 3.0 -+ 0.0 2.7 + 0.7 0.10 
*p < 0.05. Data presented are mean value _+SD, unless otherwise indicated. 
Abbreviations as in Table 1. 
Observations from these studies have led to the hypothesis 
that exercise capacity in patients with advanced heart failure 
may in fact be more closely related to right ventricular than left 
ventricular performance (38). Both a decrease in pulmonary 
vascular resistance (with concomitant decrease inright ventric- 
ular afterload) and recruitment of the contactile reserve of 
right ventricular f ee wall contribute to the normal increase in 
right ventricular ejection fraction seen during exercise in 
healthy volunteers (28,29). Inadequate right ventricular free 
wall systolic performance (from previous infarction or isch- 
emia) or contractile reserve (from increased right ventricular 
afterload secondary to elevated pulmonary vascular esistance 
or pulmonary hypertension) both may prohibit the normal 
increase in right ventricular ejection fraction and right-sided 
cardiac output. 
Peak Vo z. Peak Vo 2 has been shown in multiple studies 
(5,21,32) to predict survival in patients with symptomatic heart 
failure. Mancini et al. (22) classified patients with advanced 
heart failure referred for evaluation for cardiac transplantation 
into two groups on the basis of peak Vo 2. Group 1 had peak 
Vo: <14 ml/kg per min (n = 35, mean Vo: 11.2 + 2.5), and 
group 2 had peak Vo 2 >14 ml/kg per rain (n = 52, mean Vo: 
19.0 _+ 4.1) during symptom-limited treadmill cardiopulmo- 
nary exercise testing. The two groups were comparable in age, 
functional class, left ventricular ejection fraction and cardiac 
index at rest; pulmonary capillary wedge pressure was signifi- 
cantly lower in group 2. One-year actuarial survival was 
reported to be significantly lower in group 1 than group 2 (70% 
vs. 94%, p < 0.005). This influential study serves as the basis 
for the current recommendation that patients with peak Vo 2 
<14 ml/kg per rain be considered for transplantation (21). 
Symptom-limited upright bicycle exercise testing as used in 
the present study may underestimate p ak Vo 2 by 5% to 10% 
compared with symptom-limited treadmill testing as used in 
the study by Mancini et al. (22) and others (21,23). However, 
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the lack of predictive power of peak Vo 2 in the present study 
probably results from differences in the study patients rather 
than the method of peak Vo 2 measurement. Although our 
patients did not differ from those studied by Mancini et al. (22) 
with regard to age, left ventricular ejection fraction or heart 
failure etiology, mean peak Vo2 was significantly ower in our 
patients (11.8 vs. 14.7 ml/kg per rain). Further, our patients 
appeared to be more limited in the distribution of their peak 
Vo2: Only five patients (7.5%) in our study achieved a Vo2 
>19 ml/kg per rain, the mean value for group 2 in the study by 
Mancini et al. (22). Although peak Vo 2 is of great importance 
in predicting overall survival in large groups of patients with 
impaired left ventricular ejection fraction but varying degress 
of functional limitation, it appears to lose its predictive value in 
more impaired and homogeneous patient groups. A similar 
loss of predictive value has been reported for left ventricular 
ejection fraction whenever it decreases <25% (1,32). 
In the present study, age- and gender-adjusted peak %Vo2 
but not nonadjusted peak Vo 2 predicted overall and event-free 
survival. Peak Vo 2 and peak %Vo 2 assess not only cardiac 
reserve, but also the adequacy of circulatory compensatory 
mechanisms inheart failure (32). Such mechanisms include the 
level of general conditioning status, muscle mass and perfusion 
and vasoregulatory autonomic reflexes (39). Given the age and 
gender dependence of these compensatory mechanisms, peak 
%Vo2 is a more sensitive indicator of functional capacity than 
peak Vo2, in a manner analogous to the superiority of age- 
adjusted rather than nonadjusted maximal heart rates during 
exercise. In the present study, peak %Vo 2 <30% was associ- 
ated with the worst, and %Vo2 >45% was associated with the 
best, overall and event-free survival. 
Exercise-related change in left or right ventricular ejection 
fraction and ventricular ejection fraction discordance. Al- 
though it has been hypothesized that the ability to augment 
right or left ventricular ejection fraction may predict functional 
capacity and prognosis in heart failure, the present study 
confirms previous smaller eports in demonstrating that the 
change in left ventricular ejection fraction or right ventricular 
ejection fraction from rest to peak exercise does not predict 
either functional capacity or prognosis. An increase or de- 
crease in right or left ventricular ejection fraction with exercise 
was not associated in univariate or multivariate analysis with 
peak Vo2, peak %Vo2, or overall or event-free survival. 
Among the previous maller studies, Szalchcic et al. (35) found 
no correlation with peak Vo 2 and change in left or right 
ventricular ejection fraction in patients with advanced heart 
failure. Higginbotham et al. (30) found no univariate or 
multivariate association between change in left ventricular 
ejection fraction with peak Vo2 or metabolic equivalents 
(METS) achieved uring bicycle ergometry. As in these two 
previous tudies, the present study also found no association 
between left ventricular end-diastolic volume index at rest or 
change in left ventricular end-diastolic volume index during 
exercise with peak Vo 2 or overall or event-free survival (30,35). 
Ventricular ejection fraction discordance did not predict 
overall and event-free survival but did predict functional 
capacity. The right and left ventricles hare common muscle 
bundles, acommon interventricular septum and the pericardial 
space (40-42). Acute decline in right ventricular systolic 
function and acute increase in right ventricular diastolic vol- 
ume have been shown to impair the systolic and diastolic 
function of the left ventricle, respectively, as a result of 
ventricular interaction (43-45). The predominant mechanism 
or mechanisms of ventricular interaction are not known, but 
constraint of ventricular diastolic filling by the presence of an 
intact pericardium or diastolic bowing of the interventricular 
septum from preferential right or left ventricular diastolic 
filling probably play an important role (46). Preserved right 
ventricular systolic function and resultant smaller ight ventric- 
ular end-diastolic volume may minimize the adverse ffects of 
right ventricular interaction on left ventricular systolic perfor- 
mance in advanced heart failure and result in improved 
functional capacity. If validated in larger studies, ventricular 
ejection discordance, a noninvasive, asily acquired measure of 
functional capacity, may be of potential use in the initial 
stratification of patients with advanced heart failure. 
Contrary to studies of patients with varying degrees of heart 
failure and functional limitation, the present study of a homo- 
geneous patient group with advanced heart failure and marked 
functional limitation found that left ventricular volumetric 
indexes uch as left ventricular end-diastolic volume index and 
left ventricular end-systolic volume index did not predict 
functional capacity or overall or event-free survival. 
Determinants of age- and gender-adjusted predicted peak 
%Voz achieved. Analysis of the univariate and multivariate 
determinants of peak %Vo 2 corroborated the important func- 
tional role of the right ventricle in advanced heart failure. In 
multivariate analysis, right ventricular ejection fraction ->0.35 
at exercise merged as the most important predictor of peak 
%Vo 2. In multivariate models, including a smaller patient 
group with complete catheterization a d first-pass rest and 
exercise radionuclide v ntriculography data, ventricular discor- 
dance and right ventricular stroke work index entered the 
model in place of right ventricular ejection fraction ->0.35 at 
exercise as the most important predictors of peak %Vo2. Thus, 
right ventricular function, measured by either ight ventricular 
ejection fraction, right and left ventricular ejection fraction 
discordance or right ventricular stroke work index, is an 
important determinant ofpeak %Vo 2 in these patients. 
Study limitations. The present study included a relatively 
small number of patients. Medical therapy had been only 
recently maximized in these patients, many of whom were 
previously suboptimally treated. Exercise testing and peak Vo2 
determinations were not performed serially in these patients. 
Symptom-limited bicycle ergometric exercise testing was used, 
which may underestimate p ak Vo 2 by 5% to 10% compared 
with symptomqimited treadmill exercise. In the present study, 
right heart cardiac catheterization within 3 weeks of exercise 
testing was performed in only 66% of patients after optimiza- 
tion of digoxin, diuretic drugs and angiotensin-converting 
enzyme inhibitors; because not all patients underwent cathe- 
terization, hemodynamic variables were not included in this 
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analysis. Further, the results of this study of patients with 
advanced heart failure may not be readily generalizable or 
applicable in predicting outcome or Vo2 in patients with a 
milder degree of heart failure. 
Summary. The present study identified rest and exercise 
right ventricular ejection fractions as important predictors of 
overall and event-free survival in patients with advanced heart 
failure. Preservation of right ventricular ejection fraction was 
the single most important predictor of overall and event-free 
survival in this referral group of patients. Peak %Vo 2 but not 
peak Vo 2 was predictive of overall and event-free survival in 
this study; this observation probably reflected the more homo- 
geneous patient group in this study compared with those in 
previous studies. The present study also identified rest or 
exercise ventricular ejection fraction and ventricular ejection 
fraction discordance as important predictors of functional 
capacity in advanced heart failure. Larger studies using first- 
pass radionuclide ventriculography in both advanced and 
milder degrees of heart failure are necessary to determine the 
prognostic value of right ventricular function and ventricular 
ejection fraction discordance in such patients. 
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